Zhang et al. [5] show that FL- and DLBCL-associated KMT2D mutations impair KMT2D enzymatic activity, leading to diminished global H3K4 methylation in germinal-center (GC) B cells and DLBCL cells. The gene discussed is KMT2D; the disease is diffuse large B-cell lymphoma.